These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 30175930)
1. A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone. Weber MA; Sever P; Juhasz A; Roberts A; Cao C J Renin Angiotensin Aldosterone Syst; 2018; 19(3):1470320318795000. PubMed ID: 30175930 [TBL] [Abstract][Full Text] [Related]
2. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil. Bakris GL; Sica D; White WB; Cushman WC; Weber MA; Handley A; Song E; Kupfer S Am J Med; 2012 Dec; 125(12):1229.e1-1229.e10. PubMed ID: 22939358 [TBL] [Abstract][Full Text] [Related]
3. Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension. Cushman WC; Bakris GL; White WB; Weber MA; Sica D; Roberts A; Lloyd E; Kupfer S Hypertension; 2012 Aug; 60(2):310-8. PubMed ID: 22710649 [TBL] [Abstract][Full Text] [Related]
4. Azilsartan medoxomil/chlorthalidone: a new fixed-dose combination antihypertensive. Pierini D; Anderson KV Ann Pharmacother; 2013 May; 47(5):694-703. PubMed ID: 23585646 [TBL] [Abstract][Full Text] [Related]
5. Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial study. Sica D; Bakris GL; White WB; Weber MA; Cushman WC; Huang P; Roberts A; Kupfer S J Clin Hypertens (Greenwich); 2012 May; 14(5):284-92. PubMed ID: 22533654 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of azilsartan medoxomil/chlortalidone fixed-dose combination in hypertensive patients uncontrolled on azilsartan medoxomil alone: A randomized trial. Collier DJ; Juhasz A; Agabiti-Rosei E; Lloyd E; Hisada M; Zhao L; Kupfer S; Caulfield MJ J Clin Hypertens (Greenwich); 2018 Oct; 20(10):1473-1484. PubMed ID: 30302936 [TBL] [Abstract][Full Text] [Related]
7. Safety, tolerability, and efficacy of azilsartan medoxomil with or without chlorthalidone during and after 8 months of treatment for hypertension. Kipnes MS; Handley A; Lloyd E; Barger B; Roberts A J Clin Hypertens (Greenwich); 2015 Mar; 17(3):183-92. PubMed ID: 25619410 [TBL] [Abstract][Full Text] [Related]
8. Effects of combining azilsartan medoxomil with amlodipine in patients with stage 2 hypertension. Weber MA; White WB; Sica D; Bakris GL; Cao C; Roberts A; Kupfer S Blood Press Monit; 2014 Apr; 19(2):90-7. PubMed ID: 24445723 [TBL] [Abstract][Full Text] [Related]
9. Azilsartan medoxomil: a review of its use in hypertension. Perry CM Clin Drug Investig; 2012 Sep; 32(9):621-39. PubMed ID: 22877322 [TBL] [Abstract][Full Text] [Related]
10. Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide. Neutel JM; Cushman WC; Lloyd E; Barger B; Handley A J Clin Hypertens (Greenwich); 2017 Sep; 19(9):874-883. PubMed ID: 28681550 [TBL] [Abstract][Full Text] [Related]
11. Azilsartan medoxomil: a new angiotensin II receptor antagonist for treatment of hypertension. Baker WL; White WB Ann Pharmacother; 2011 Dec; 45(12):1506-15. PubMed ID: 22116996 [TBL] [Abstract][Full Text] [Related]
13. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. White WB; Weber MA; Sica D; Bakris GL; Perez A; Cao C; Kupfer S Hypertension; 2011 Mar; 57(3):413-20. PubMed ID: 21282560 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review. Katsi V; Michalakeas C; Soulaidopoulos S; Antonopoulos AS; Vlachopoulos C; Tousoulis D; Tsioufis K Curr Hypertens Rev; 2021; 17(3):217-227. PubMed ID: 33438552 [TBL] [Abstract][Full Text] [Related]
15. Azilsartan medoxomil for the treatment of hypertension. Vasiliou S Drugs Today (Barc); 2011 Sep; 47(9):647-51. PubMed ID: 21971539 [TBL] [Abstract][Full Text] [Related]
20. The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure. Bakris GL; Sica D; Weber M; White WB; Roberts A; Perez A; Cao C; Kupfer S J Clin Hypertens (Greenwich); 2011 Feb; 13(2):81-8. PubMed ID: 21272195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]